- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
StemCells Inc+ Add to Watchlist
STEM:US0.8985 USD 0.0253 2.90%
As of 17:10:00 ET on 12/24/2014.
Company Profile for StemCells Inc (STEM)
StemCells, Inc. is a biotechnology company. The Company discovers, develops, and commercializes stem cell-based therapies to treat diseases of the central nervous system, liver, and the pancreas. StemCells seeks to repair or repopulate neural, or other tissue that has been damaged or lost as a result of disease or injury.
Key Executives for StemCells Inc (STEM)
|Martin M McGlynnPresident/CEO||Stephen HuhnVP:CNS Clinical Rsch/Chief Medical Ofcr|
|Gregory T SchiffmanExec VP:Finance/CFO||Ann TsukamotoExec VP:Strategic Alliances|
|Kenneth B Stratton "Ken"Secretary/General Counsel|